Delhi Startup Unicorn: How NeuroSync Labs Built $85M Valuation

In a nondescript office building tucked between the warehouses and manufacturing units of Okhla Industrial Area, Phase III, something quietly remarkable is happening. NeuroSync Labs, founded just four years ago by former IIT Delhi researcher Priya Sharma, has become one of Delhi's fastest-growing deep-tech ventures—and a beacon for how the capital's startup ecosystem is maturing beyond typical software and services plays.

The company, which specializes in AI-driven biomedical device development, recently closed a $12 million Series B round led by prominent Silicon Valley investors, valuing the startup at $85 million. More significantly, it has attracted over 150 engineers and scientists to its Delhi headquarters, in a city long overshadowed by Bangalore's tech dominance.

"Delhi has always been seen as a business and administrative hub, not an innovation centre," Sharma explained during a recent conversation at the company's Okhla facility. "But that narrative is changing. We have talent, capital, and increasingly, the infrastructure to build world-class technology here."

That infrastructure shift is visible across the capital. The Delhi government's Innovation District initiative in Dwarka, launched in 2023, now houses over 80 registered startups. Meanwhile, established venture funds like Accel and Sequoia have expanded their Delhi presence, with dedicated partner teams scouting early-stage founders in neighbourhoods like Malviya Nagar and Greater Kailash, traditional business hubs now becoming innovation hotbeds.

NeuroSync's trajectory reflects this broader momentum. The company's devices—which use machine learning to improve surgical precision—are already deployed in 47 hospitals across India and Southeast Asia. The company's path from Sharma's lab at IIT Delhi to profitability took just three years, faster than most comparable deep-tech ventures globally.

What sets NeuroSync apart, according to analysts, is its hybrid approach: maintaining R&D in Delhi while leveraging the city's robust manufacturing and regulatory expertise. Unlike pure software plays that often relocate to tech hubs, Sharma's business model requires physical presence in India's medical device ecosystem.

The startup is now planning to double its Delhi workforce by 2027 and establish a dedicated innovation lab in the Delhi government's Dwarka corridor. It's also mentoring a cohort of 12 early-stage biotech founders through its recently launched accelerator programme.

For Delhi's entrepreneurial community, NeuroSync's rise carries symbolic weight. "It proves that deep-tech innovation isn't geographically limited," said Rajesh Gupta, senior partner at Delhi-based venture firm Momentum Partners. "If Sharma can build a $85 million biotech company here, others will follow." And that, perhaps, is Delhi's emerging startup story: not imitation of Silicon Valley or Bangalore, but a distinctly local path to global innovation.

This article was compiled by AI from the sources linked above and screened before publishing. See our editorial standards.